Diatrizoate
- Generic Name
- Diatrizoate
- Brand Names
- Cystografin, Cystografin Dilute, Gastrografin, Hypaque, Md-Gastroview
- Drug Type
- Small Molecule
- Chemical Formula
- C11H9I3N2O4
- CAS Number
- 117-96-4
- Unique Ingredient Identifier
- 5UVC90J1LK
Overview
A commonly used x-ray contrast medium. As diatrizoate meglumine and as Diatrizoate sodium, it is used for gastrointestinal studies, angiography, and urography.
Background
A commonly used x-ray contrast medium. As diatrizoate meglumine and as Diatrizoate sodium, it is used for gastrointestinal studies, angiography, and urography.
Indication
Used, alone or in combination, for a wide variety of diagnostic imaging methods, including angiography, urography, cholangiography, computed tomography, hysterosalpingography, and retrograde pyelography. It can be used for imaging the gastrointestinal tract in patients allergic to barium.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
Diatrizoate Meglumine and Diatrizoate Sodium
Manufacturer:Guardian Drug Company
Route:ORAL, RECTAL
Strength:100 mg in 1 mL
Approved: 2020/12/18
NDC:53041-688
Diatrizoate Meglumine and Diatrizoate Sodium
Manufacturer:Guardian Drug Company
Route:ORAL, RECTAL
Strength:100 mg in 1 mL
Approved: 2020/12/18
NDC:53041-690
Diatrizoate Meglumine and Diatrizoate Sodium
Manufacturer:Camber Pharmaceuticals, Inc.
Route:ORAL, RECTAL
Strength:100 mg in 1 mL
Approved: 2023/12/18
NDC:31722-019
MD GASTROVIEW
Manufacturer:Liebel-Flarsheim Company LLC
Route:ORAL, RECTAL
Strength:100 mg in 1 mL
Approved: 2017/02/15
NDC:0019-4816
Gastrografin
Manufacturer:Bracco Diagnostics Inc
Route:ORAL, RECTAL
Strength:100 mg in 1 mL
Approved: 2018/04/23
NDC:0270-0445
Singapore Approved Products
GASTROGRAFIN SOLUTION
Manufacturer:BERLIMED S A
Form:SOLUTION
Strength:0.1 g/ml
Online:Yes
Approved: 1991/05/14
Approval:SIN05846P
GASTROGRAFIN SOLUTION
Manufacturer:BERLIMED S A
Form:SOLUTION
Strength:0.66 g/ml
Online:Yes
Approved: 1991/05/14
Approval:SIN05846P
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath